Form 8-K - Current report:
SEC Accession No. 0001104659-25-061663
Filing Date
2025-06-23
Accepted
2025-06-23 16:01:52
Documents
12
Period of Report
2025-06-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2518581d1_8k.htm   iXBRL 8-K 31086
  Complete submission text file 0001104659-25-061663.txt   192090

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gdnsf-20250620.xsd EX-101.SCH 3035
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE gdnsf-20250620_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gdnsf-20250620_pre.xml EX-101.PRE 22371
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2518581d1_8k_htm.xml XML 3345
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Vireo Growth Inc. (Filer) CIK: 0001771706 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56225 | Film No.: 251064920
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)